Core Insights - A new study from the University of Turku in Finland identifies specific changes in the lymphatic system that can help doctors early detect aggressive and high-recurrence risk oral cancers [1][2] - The research analyzed samples from approximately 300 Finnish early-stage oral cancer patients, revealing an increase in dividing lymphatic endothelial cells in tumor tissues, which correlates with higher recurrence and mortality risks [1] - The study emphasizes the importance of early identification of aggressive cancers to potentially reduce recurrence and mortality through treatment [1] Group 1 - The study found that the number of dividing lymphatic endothelial cells in cancer patients is significantly higher than in healthy individuals, indicating a potential biomarker for aggressive oral cancer [1] - Current early treatment for oral cancer primarily relies on surgery, but there is a lack of reliable methods for selecting adjuvant therapies [1] - Identifying new biomarkers could enable more effective treatment for high-risk patients while sparing those with better prognoses from unnecessary severe side effects of adjuvant therapies [1] Group 2 - The research findings have been published in the journal Cell Reports Medicine, with plans to explore the predictive value of related protein markers in other cancer types [2] - According to global cancer databases, approximately 188,000 deaths from oral cancer occurred worldwide in 2022, highlighting the significance of improving early detection methods [3]